The research, published in Experimental Biology and Medicine earlier this month, analyzed pancreatic cancer patients’ genetic data from several databases including the National Cancer Institute’s The Cancer Genome Atlas (TCGA) and the National Center for Biotechnology Information’s Gene Expression Omnibus (GEO). Read more . . .
Researchers from Zhongshan Hospital in Shanghai have developed a five-gene signature that may better characterize pancreatic cancer patients’ survival and benefit from chemotherapy.